Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 10, 2026
Salim Syed's Stock Ratings
Mizuho Analyst
Salim Syed is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
-2.49%
Smart Score
Overall Average Return Percentile
30th
Number of Ratings
98
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/01/2026 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | 68.32% | $96 → $110 | Maintains | Outperform | Get Alert | |
| 09/01/2026 | ASMB | Buy Now | Assembly Biosciences | $23.52 | 91.33% | $53 → $45 | Maintains | Outperform | Get Alert | |
| 08/18/2026 | AMGN | Buy Now | Amgen | $414.17 | -15.01% | $303 → $352 | Maintains | Neutral | Get Alert | |
| 08/18/2026 | ELVN | Buy Now | Enliven Therapeutics | $40.98 | 78.14% | $62 → $73 | Maintains | Outperform | Get Alert | |
| 08/04/2026 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 560.2% | $27 → $23 | Maintains | Outperform | Get Alert | |
| 08/04/2026 | INCY | Buy Now | Incyte | $112.79 | 21.46% | $121 → $137 | Maintains | Outperform | Get Alert | |
| 08/04/2026 | BIIB | Buy Now | Biogen | $225.71 | 6.77% | $221 → $241 | Maintains | Outperform | Get Alert | |
| 06/24/2026 | CYTK | Buy Now | Cytokinetics | $62.91 | 87.57% | $100 → $118 | Maintains | Outperform | Get Alert | |
| 06/16/2026 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | 46.9% | $106 → $96 | Maintains | Outperform | Get Alert | |
| 06/16/2026 | AMGN | Buy Now | Amgen | $414.17 | -26.84% | $295 → $303 | Maintains | Neutral | Get Alert | |
| 06/15/2026 | BIIB | Buy Now | Biogen | $225.71 | -2.09% | $236 → $221 | Maintains | Outperform | Get Alert | |
| 06/15/2026 | ASMB | Buy Now | Assembly Biosciences | $23.52 | 91.33% | $40 → $45 | Maintains | Outperform | Get Alert | |
| 06/02/2026 | ELVN | Buy Now | Enliven Therapeutics | $40.98 | 51.29% | $45 → $62 | Maintains | Outperform | Get Alert | |
| 05/27/2026 | IPSC | Buy Now | Century Therapeutics | $1.47 | 444.22% | → $8 | Initiates | → Outperform | Get Alert | |
| 04/30/2026 | STRO | Buy Now | Sutro Biopharma | $14.19 | 252.36% | → $50 | Initiates | → Outperform | Get Alert | |
| 04/28/2026 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | 62.2% | $106 → $106 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/31/2026 | AUTL | Buy Now | Autolus Therapeutics | $1.83 | 446.45% | $12 → $10 | Maintains | Outperform | Get Alert | |
| 03/31/2026 | SNDX | Buy Now | Syndax Pharmaceuticals | $17.75 | 142.25% | $45 → $43 | Maintains | Outperform | Get Alert | |
| 03/31/2026 | NKTX | Buy Now | Nkarta | $2.26 | 430.97% | $14 → $12 | Maintains | Outperform | Get Alert | |
| 03/25/2026 | ELVN | Buy Now | Enliven Therapeutics | $40.98 | 9.81% | $41 → $45 | Maintains | Outperform | Get Alert | |
| 03/25/2026 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 675.02% | $22 → $27 | Maintains | Outperform | Get Alert | |
| 03/18/2026 | CYTK | Buy Now | Cytokinetics | $62.91 | 58.96% | $84 → $100 | Maintains | Outperform | Get Alert | |
| 03/18/2026 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | 62.2% | $91 → $106 | Maintains | Outperform | Get Alert | |
| 03/10/2026 | MAZE | Buy Now | Maze Therapeutics | $27.11 | 257.8% | → $97 | Initiates | → Outperform | Get Alert | |
| 12/08/2025 | INCY | Buy Now | Incyte | $112.79 | 7.28% | $90 → $121 | Upgrade | Neutral → Outperform | Get Alert | |
| 11/20/2025 | ASMB | Buy Now | Assembly Biosciences | $23.52 | 70.07% | $29 → $40 | Maintains | Outperform | Get Alert | |
| 06/10/2025 | NKTX | Buy Now | Nkarta | $2.26 | 519.47% | $16 → $14 | Maintains | Outperform | Get Alert | |
| 05/29/2025 | CYTK | Buy Now | Cytokinetics | $62.91 | 33.52% | $103 → $84 | Maintains | Outperform | Get Alert | |
| 05/07/2025 | BIIB | Buy Now | Biogen | $225.71 | -25.13% | $207 → $169 | Maintains | Outperform | Get Alert | |
| 05/07/2025 | AMGN | Buy Now | Amgen | $414.17 | -32.39% | $235 → $280 | Maintains | Neutral | Get Alert | |
| 05/05/2025 | GILD | Buy Now | Gilead Sciences | $151.20 | -22.62% | $100 → $117 | Maintains | Outperform | Get Alert | |
| 11/21/2024 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 531.49% | $19 → $22 | Maintains | Outperform | Get Alert | |
| 11/21/2024 | NKTX | Buy Now | Nkarta | $2.26 | 607.96% | $20 → $16 | Maintains | Outperform | Get Alert | |
| 11/21/2024 | GILD | Buy Now | Gilead Sciences | $151.20 | -33.86% | $90 → $100 | Maintains | Outperform | Get Alert | |
| 11/21/2024 | CYTK | Buy Now | Cytokinetics | $62.91 | 63.73% | $99 → $103 | Maintains | Outperform | Get Alert | |
| 11/21/2024 | BIIB | Buy Now | Biogen | $225.71 | -8.29% | $251 → $207 | Maintains | Outperform | Get Alert | |
| 09/10/2024 | PCVX | Buy Now | Vaxcyte | $71.12 | 129.19% | $113 → $163 | Maintains | Outperform | Get Alert | |
| 08/16/2024 | ATRA | Buy Now | Atara Biotherapeutics | $9.48 | 89.87% | $25 → $18 | Upgrade | Neutral → Outperform | Get Alert | |
| 08/06/2024 | BIIB | Buy Now | Biogen | $225.71 | 11.2% | $277 → $251 | Maintains | Outperform | Get Alert | |
| 06/25/2024 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 445.38% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/09/2024 | AMGN | Buy Now | Amgen | $414.17 | -43.26% | $223 → $235 | Maintains | Neutral | Get Alert | |
| 04/09/2024 | ELVN | Buy Now | Enliven Therapeutics | $40.98 | -17.03% | → $34 | Initiates | → Buy | Get Alert | |
| 03/22/2024 | NKTX | Buy Now | Nkarta | $2.26 | 1006.19% | $31 → $25 | Maintains | Buy | Get Alert | |
| 03/12/2024 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 445.38% | $10 → $19 | Maintains | Buy | Get Alert | |
| 03/12/2024 | PCVX | Buy Now | Vaxcyte | $71.12 | 58.89% | $69 → $113 | Maintains | Buy | Get Alert | |
| 03/06/2024 | CYTK | Buy Now | Cytokinetics | $62.91 | 57.37% | $103 → $99 | Maintains | Buy | Get Alert | |
| 03/06/2024 | CRSP | Buy Now | CRISPR Therapeutics | $53.75 | 84.19% | $82 → $99 | Maintains | Buy | Get Alert | |
| 03/05/2024 | NKTX | Buy Now | Nkarta | $2.26 | 1271.68% | $9 → $31 | Maintains | Buy | Get Alert | |
| 03/05/2024 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -18.9% | $60 → $53 | Maintains | Buy | Get Alert | |
| 02/22/2024 | GILD | Buy Now | Gilead Sciences | $151.20 | -40.48% | $101 → $90 | Maintains | Buy | Get Alert | |
| 02/22/2024 | BIIB | Buy Now | Biogen | $225.71 | 22.72% | $355 → $277 | Maintains | Buy | Get Alert | |
| 01/22/2024 | CYTK | Buy Now | Cytokinetics | $62.91 | 63.73% | $80 → $103 | Maintains | Buy | Get Alert | |
| 12/08/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.75 | 52.56% | $82 → $82 | Reiterates | Buy → Buy | Get Alert | |
| 12/07/2023 | PCVX | Buy Now | Vaxcyte | $71.12 | -2.98% | → $69 | Initiates | → Buy | Get Alert | |
| 11/16/2023 | NKTX | Buy Now | Nkarta | $2.26 | 298.23% | $15 → $9 | Maintains | Buy | Get Alert | |
| 11/09/2023 | ATRA | Buy Now | Atara Biotherapeutics | $9.48 | -89.45% | $31 → $1 | Downgrade | Buy → Neutral | Get Alert | |
| 09/27/2023 | CRSP | Buy Now | CRISPR Therapeutics | $53.75 | 52.56% | → $82 | Initiates | → Buy | Get Alert | |
| 08/28/2023 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -8.19% | → $60 | Reiterates | Buy → Buy | Get Alert | |
| 08/14/2023 | BIIB | Buy Now | Biogen | $225.71 | 48.42% | $340 → $335 | Maintains | Buy | Get Alert | |
| 08/14/2023 | NKTX | Buy Now | Nkarta | $2.26 | 563.72% | $26 → $15 | Maintains | Buy | Get Alert | |
| 08/14/2023 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -8.19% | $50 → $60 | Maintains | Buy | Get Alert | |
| 08/14/2023 | AMGN | Buy Now | Amgen | $414.17 | -46.16% | $214 → $223 | Maintains | Neutral | Get Alert | |
| 05/24/2023 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 187.04% | $13 → $10 | Maintains | Buy | Get Alert | |
| 05/08/2023 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -55.62% | $23 → $29 | Maintains | Buy | Get Alert | |
| 04/14/2023 | WVE | Buy Now | WAVE Life Sciences | $3.48 | 273.16% | → $13 | Reiterates | → Buy | Get Alert | |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | — | — | $12 → $6 | Maintains | Buy | Get Alert | |
| 02/14/2023 | GILD | Buy Now | Gilead Sciences | $151.20 | -33.2% | $88 → $101 | Maintains | Buy | Get Alert | |
| 02/07/2023 | ATRA | Buy Now | Atara Biotherapeutics | $9.48 | 227% | → $31 | Reiterates | → Buy | Get Alert | |
| 11/16/2022 | UBX | Buy Now | Unity Biotechnology | — | — | $80 → $12 | Maintains | Buy | Get Alert | |
| 11/16/2022 | NKTX | Buy Now | Nkarta | $2.26 | 1050.44% | $81 → $26 | Maintains | Buy | Get Alert | |
| 11/16/2022 | CHRS | Buy Now | Coherus BioSciences | $1.09 | 1826.61% | $28 → $21 | Maintains | Buy | Get Alert | |
| 11/16/2022 | ASMB | Buy Now | Assembly Biosciences | $23.52 | -87.24% | $14 → $3 | Maintains | Buy | Get Alert | |
| 11/08/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -41.8% | $75 → $88 | Maintains | Buy | Get Alert | |
| 11/01/2022 | BIIB | Buy Now | Biogen | $225.71 | 43.99% | $270 → $325 | Maintains | Buy | Get Alert | |
| 09/28/2022 | BIIB | Buy Now | Biogen | $225.71 | 19.62% | $207 → $270 | Upgrade | Neutral → Buy | Get Alert | |
| 08/24/2022 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -64.8% | $25 → $23 | Maintains | Buy | Get Alert | |
| 08/16/2022 | UBX | Buy Now | Unity Biotechnology | — | — | $7 → $8 | Maintains | Buy | Get Alert | |
| 08/16/2022 | CHRS | Buy Now | Coherus BioSciences | $1.09 | 2468.81% | $25 → $28 | Maintains | Buy | Get Alert | |
| 08/16/2022 | ATRA | Buy Now | Atara Biotherapeutics | $9.48 | 227% | $39 → $31 | Maintains | Buy | Get Alert | |
| 05/20/2022 | CHRS | Buy Now | Coherus BioSciences | $1.09 | 2193.58% | $30 → $25 | Maintains | Buy | Get Alert | |
| 05/16/2022 | CYTK | Buy Now | Cytokinetics | $62.91 | 27.17% | $54 → $80 | Maintains | Buy | Get Alert | |
| 05/10/2022 | AMGN | Buy Now | Amgen | $414.17 | -49.78% | $202 → $208 | Maintains | Neutral | Get Alert | |
| 02/08/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -50.4% | $81 → $75 | Maintains | Buy | Get Alert | |
| 01/12/2022 | BIIB | Buy Now | Biogen | $225.71 | -8.29% | $270 → $207 | Maintains | Neutral | Get Alert | |
| 12/01/2021 | CYTK | Buy Now | Cytokinetics | $62.91 | -14.16% | $45 → $54 | Maintains | Buy | Get Alert | |
| 11/22/2021 | AMGN | Buy Now | Amgen | $414.17 | -53.16% | $222 → $194 | Maintains | Neutral | Get Alert | |
| 11/10/2021 | UBX | Buy Now | Unity Biotechnology | — | — | $5 → $7 | Upgrade | Neutral → Buy | Get Alert | |
| 10/26/2021 | BIIB | Buy Now | Biogen | $225.71 | 19.62% | $300 → $270 | Maintains | Neutral | Get Alert | |
| 08/02/2021 | BIIB | Buy Now | Biogen | $225.71 | 32.91% | $244 → $300 | Maintains | Neutral | Get Alert | |
| 03/04/2021 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | 31.6% | $56 → $86 | Maintains | Buy | Get Alert | |
| 11/19/2020 | CHRS | Buy Now | Coherus BioSciences | $1.09 | 2652.29% | $35 → $30 | Maintains | Buy | Get Alert | |
| 11/02/2020 | AMGN | Buy Now | Amgen | $414.17 | -48.09% | $260 → $215 | Maintains | Neutral | Get Alert | |
| 10/27/2020 | BIIB | Buy Now | Biogen | $225.71 | 24.94% | $316 → $282 | Maintains | Neutral | Get Alert | |
| 08/18/2020 | UBX | Buy Now | Unity Biotechnology | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 08/04/2020 | NKTX | Buy Now | Nkarta | $2.26 | 1404.42% | → $34 | Initiates | → Buy | Get Alert | |
| 05/05/2020 | CYTK | Buy Now | Cytokinetics | $62.91 | -50.72% | → $31 | Initiates | → Buy | Get Alert | |
| 02/25/2020 | BIIB | Buy Now | Biogen | $225.71 | 40% | $300 → $316 | Maintains | Neutral | Get Alert | |
| 02/19/2020 | BBIO | Buy Now | BridgeBio Pharma | $65.35 | -21.96% | → $51 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved